ACE and acute coronary syndrome: A systematic review and meta-analysis of 28 studies involving patients with acute coronary syndromes found that women were less adherent to lipid-lowering therapies, whereas no significant gender differences were reported for antiplatelet agents or ACE inhibitors [24].